Quantum biology and human carcinogenesis

Quantum-mediated effects have been observed in biological systems. We have previously discussed basis-dependent quantum selection as a mechanism for directed adaptive mutation, a process in which selective pressure specifically induces mutation in those genes involved in the adaptive response. Tumor progression in cancer easily lends itself to the adaptive evolutionary perspective, as the Darwinian combination of heritable variations together with selection of the better proliferating variants are believed to play a major role in multistep carcinogenesis. Adaptive mutation may play a role in carcinogenesis; accordingly, we propose that the principles of quantum biology are involved in directed adaptive mutation processes that promote tumor formation. In this paper, we discuss the intersection between quantum mechanics, biology, adaptive evolution, and cancer, and present general models by which adaptive mutation may influence neoplastic initiation and progression. As a potential theoretical and experimental model, we use colorectal cancer. Our model of "quantum cancer" suggests experiments to evaluate directed adaptive mutation in tumorigenesis, and may have important implications for cancer therapeutics.

[1]  The EBG System of E. coli: Origin and Evolution of a Novel β-Galactosidase for the Metabolism of Lactose , 2003 .

[2]  E. Bieberich,et al.  Probing quantum coherence in a biological system by means of DNA amplification. , 2000, Bio Systems.

[3]  J. Reiter,et al.  Wounding mobilizes hair follicle stem cells to form tumors , 2011, Proceedings of the National Academy of Sciences.

[4]  A. Sartorelli,et al.  Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate , 2004, International journal of cancer.

[5]  V. Ogryzko,et al.  A quantum-theoretical approach to the phenomenon of directed mutations in bacteria (hypothesis). , 1997, Bio Systems.

[6]  T. Vincent,et al.  An evolutionary model of carcinogenesis. , 2003, Cancer research.

[7]  Vasily Ogryzko,et al.  Quantum biology at the cellular level - Elements of the research program , 2013, Biosyst..

[8]  W. G. Cooper.  Coherent states as consequences of keto‐amino→ enol‐imine hydrogen bond arrangements driven by quantum uncertainty limits on amino DNA protons , 2012 .

[9]  J. Cairns,et al.  Mechanisms of directed mutation. , 1992, Genetics.

[10]  B. Hall,et al.  Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Jackson,et al.  The mutation rate and cancer. , 1998, Genetics.

[12]  B. Hall.  Experimental evolution of Ebg enzyme provides clues about the evolution of catalysis and to evolutionary potential. , 1999, FEMS microbiology letters.

[13]  M. Kimmel.  Evolution and cancer: a mathematical biology approach , 2010, Biology Direct.

[14]  T. Karpinets,et al.  Model of the developing tumorigenic phenotype in mammalian cells and the roles of sustained stress and replicative senescence. , 2004, Journal of theoretical biology.

[15]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[16]  B. Hall.  Adaptive Mutagenesis at ebgR Is Regulated by PhoPQ , 1998, Journal of bacteriology.

[17]  C. Seife.  Cold Numbers Unmake the Quantum Mind , 2000, Science.

[18]  V. Ogryzko,et al.  Erwin Schroedinger, Francis Crick and epigenetic stability , 2007, Biology Direct.

[19]  B. Hall,et al.  Spontaneous point mutations that occur more often when advantageous than when neutral. , 1990, Genetics.

[20]  J. Roth,et al.  Multiple pathways of selected gene amplification during adaptive mutation , 2006, Proceedings of the National Academy of Sciences.

[21]  Adaptive mutagenesis: a process that generates almost exclusively beneficial mutations , 1998 .

[22]  M. Yamaoka,et al.  Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells , 2005, The Prostate.

[23]  Martin A. Nowak,et al.  The role of chromosomal instability in tumor initiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Bordonaro,et al.  Extreme Fluctuations in Wnt/beta-Catenin Signaling as an Approach for Colon Cancer Prevention and Therapy , 2012 .

[25]  T. Karpinets,et al.  Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. , 2005, Carcinogenesis.

[26]  J. Mariadason,et al.  Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[27]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Stadhouders,et al.  The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay. , 2010, The Journal of molecular diagnostics : JMD.

[29]  B. Hall.  Selection-induced mutations. , 1992, Current opinion in genetics & development.

[30]  A. Sartorelli,et al.  The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. , 2007, Experimental cell research.

[31]  Willis Grant Cooper,et al.  Evidence for transcriptase quantum processing implies entanglement and decoherence of superposition proton states , 2009, Biosyst..

[32]  Patricia L. Foster.  Stress-Induced Mutagenesis in Bacteria , 2007, Critical reviews in biochemistry and molecular biology.

[33]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[34]  β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis , 2011, Gut.

[35]  T. May,et al.  Experimental Design to Evaluate Directed Adaptive Mutation in Mammalian Cells , 2014, JMIR research protocols.

[36]  B. Hall.  Selection-induced mutations occur in yeast. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Lawrence D True,et al.  Human cancers express a mutator phenotype , 2006, Proceedings of the National Academy of Sciences.

[38]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[39]  J. Overbaugh,et al.  The origin of mutants , 1988, Nature.

[40]  Max Tegmark,et al.  The importance of quantum decoherence in brain processes , 1999, ArXiv.

[41]  Willis Grant Cooper,et al.  Accuracy in Biological Information Technology Involves Enzymatic Quantum Processing and Entanglement of Decohered Isomers , 2011, Inf..

[42]  R. Fodde,et al.  The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. , 2002, Human molecular genetics.

[43]  Andrei Khrennikov,et al.  Quantum-like model of partially directed evolution. , 2017, Progress in biophysics and molecular biology.

[44]  R. Goldbohm,et al.  APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. , 2004, Carcinogenesis.

[45]  B. Hall.  On the specificity of adaptive mutations. , 1997, Genetics.

[46]  W. Stein,et al.  Analysis of cancer incidence data on the basis of multistage and clonal growth models. , 1991, Advances in cancer research.

[47]  J. Cairns,et al.  Adaptive reversion of a frameshift mutation in Escherichia coli. , 1991, Genetics.